| CTRI Number |
CTRI/2024/04/065514 [Registered on: 10/04/2024] Trial Registered Prospectively |
| Last Modified On: |
12/04/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Other (Specify) [Therapeutic] |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A Clinical Trial to study the effects of two drugs, Tuttha Pratisaran and Kushthadi Varti in married women of reproductive age group having Cervical Erosion. |
|
Scientific Title of Study
|
Effect of Tuttha Pratisaran and Kushthadi Varti in management of Cervical Erosion in married women of reproductive age group: A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Arpita Maulik Shah |
| Designation |
PhD Scholar |
| Affiliation |
Government Ayurved College, Nagpur |
| Address |
Government Ayurved College,
Department of Prasutitantra Streerog, 2nd Floor,
Raje Raghuji Nagar, Umred Road,Sakkardara Chowk, Nagpur -440024 Raje Raghuji Nagar, Umred Road,Sakkardara Chowk, Nagpur -440024 Nagpur MAHARASHTRA 440024 India |
| Phone |
9890201302 |
| Fax |
|
| Email |
arpita1801@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Manoj V Gaikwad |
| Designation |
Professor & HOD ( PhD Guide) |
| Affiliation |
RA Podar Ayurved Medical College and Hospital, |
| Address |
RA Podar Ayurved Medical College ,
Dept of Prasutitantra & Streeroga, Annie Besant Road, Worli, Mumbai- RA Podar Ayurved Medical College and Hospital,
Annie Besant Road, Worli, Mumbai-400018 Mumbai MAHARASHTRA 400018 India |
| Phone |
9822752816 |
| Fax |
|
| Email |
drmanojvgaikwad@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Arpita Maulik Shah |
| Designation |
PhD Scholar |
| Affiliation |
Government Ayurved College, Nagpur |
| Address |
Government Ayurved College,
Department of Prasutitantra and Streerog, 2nd Floor,
Raje Raghuji Nagar, Umred Road,Sakkardara Chowk, Nagpur -440024 Raje Raghuji Nagar, Umred Road,Sakkardara Chowk, Nagpur -440024 Nagpur MAHARASHTRA 440024 India |
| Phone |
9890201302 |
| Fax |
|
| Email |
arpita1801@gmail.com |
|
|
Source of Monetary or Material Support
|
| Government Ayurved College,
Raje Raghuji Nagar, Umred Road, Nagpur 440024
|
|
|
Primary Sponsor
|
| Name |
Dr Arpita Maulik Shah |
| Address |
Government Ayurved College and Hospital, Department of Prasutitantra and Streerog, 2nd Floor, Raje Raghuji Nagar, Umred Road, Nagpur-440 024 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Bhausaheb Mulak Ayurved Mahavidyalaya Nandanvan Nagpur |
KDK Campus, Great Nag Road, NAndanvan, Nagpur- 440009 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Arpita Maulik Shah |
Bhausaheb Mulak Ayurved Mahavidyalaya |
OPD No. 5, Prasutitantra Streerog OPD, Bhausaheb Mulak Ayurved Mahavidyalaya, KDK Campus, Great Nag Road, Nandanvan, Nagpur 440009 Nagpur MAHARASHTRA |
9890201302
arpita1801@gmail.com |
| Dr Arpita Maulik Shah |
Government Ayurved College |
OPD No. 42, Streerog- Prasutitantra OPD, Government Ayurved College, Raje Raghuji Nagar, Umred Road,Sakkardara Chowk, Nagpur -440024 Nagpur MAHARASHTRA |
9890201302
arpita1801@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| IEC, BMAM, Nandanvan, Nagpur |
Approved |
| IEC, Government Ayurved College, Nagpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N86||Erosion and ectropion of cervix uteri. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | pratisAraNam, पà¥à¤°à¤¤à¤¿à¤¸à¤¾à¤°à¤£à¤®à¥ | (Procedure Reference: Sushrut Vrana Chikitsa, Procedure details: Tuttha Pratisaran
Under aseptic precautions TUTTHA will be applied on erosion site with the help of gauze piece and artery forceps till the count of 100(Vakshatam).
250 mg to 1 gm (according to area of erosion)
For 7 days after cessation of menses
) (1) Medicine Name: Tuttha, Reference: API, Volume 1, Pg83, Route: Vaginal, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: od, Duration: 7 Days | | 2 | Comparator Arm | Procedure | - | vartiH, वरà¥à¤¤à¤¿à¤ƒ | (Procedure Reference: Charak Yonivyapad Chikitsa, Procedure details: Kushthadi Varti
Under aseptic precautions KUSHTHADI VARTI will be inserted vaginally near erosion site for
1 muhurt (48 minutes).
1 Varti inserted vaginally once in a day
For 7 days after cessation of menses
) (1) Medicine Name: Kushthadi Varti, Reference: Charak Yonivyapad Chikitsa, Route: Vaginal, Dosage Form: Varti/ Suppository, Dose: 1(NA), Frequency: od, Duration: 7 Days |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Female |
| Details |
1.Patients having signs and symptoms who fulfill the diagnostic criteria for Cervical Erosion.
2.Patient willing to give consent for the study. |
|
| ExclusionCriteria |
| Details |
1. Cervical or Uterine Malignancy.
2. Pregnant patient.
3. Systemic Diseases like Diabetes Mellitus.
4. Infections like HIV, VDRL, STD, HPV.
5. Cervical polyp.
6. Puerperium
7. Patient unwilling to give consent.
|
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
To evaluate the efficacy of Tuttha Pratisaran and Kushthadi Varti in the management of cervical erosion with percentage reduction in size of cervical Erosion.
|
Day 0, Day 7, Day 30
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Effect of Tuttha Pratisaran on overall improvement in the healing of cervical erosion by objective criteria, Vaginal pH and Pap Smear Examination.
|
Secondary End points -
Effect of Tuttha Pratisaran on overall improvement in the healing of cervical erosion by objective criteria, Vaginal pH and Pap Smear Examination before treatment(day 0) and after treatment(day 30)
|
|
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
30/04/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
| This study is a randomized, parallel group, open labelled, controlled clinical trial to evaluate the effectiveness of TUTTHA PRATISARAN 1gm daily on erosion site with KUSHTHADI VARTI administered once daily vaginally for 7 days in patients of age 18 - 45 years having cervical erosion. The primary outcome measures will be relief from the symptoms of cervical erosion like Vaginal discharge, odour, pruritis, backache, lower abdominal pain, burning micturation and cervical tenderness before and after treatment on day 30. The secondary outcome measures will be overall improvement in the healing of cervical erosion by examination of Vaginal pH and PAP Smear before and after treatment on day 30. The results obtained will be analysed statistically to draw conclusions from the study. | |